Cargando…
SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
The novel coronavirus SARS-CoV-2 was first identified in China in December 2019 and has since spread worldwide. People with Cystic Fibrosis (CF) have reduced survival mainly because of respiratory failure due to chronic pulmonary infections. Therefore, CF patients should be considered to have an inc...
Autores principales: | Fainardi, Valentina, Longo, Francesco, Chetta, Alfredo, Esposito, Susanna, Pisi, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716958/ https://www.ncbi.nlm.nih.gov/pubmed/32921729 http://dx.doi.org/10.23750/abm.v91i3.10391 |
Ejemplares similares
-
Short-Term Effects of High-Frequency Chest Compression and Positive Expiratory Pressure in Patients With Cystic Fibrosis
por: Fainardi, Valentina, et al.
Publicado: (2011) -
Telemedicine and Its Application in Cystic Fibrosis
por: Fainardi, Valentina, et al.
Publicado: (2023) -
Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features
por: Iannarella, Rosanna, et al.
Publicado: (2020) -
Nutritional Care in Children with Cystic Fibrosis
por: Mariotti Zani, Elena, et al.
Publicado: (2023) -
Impact of CFTR Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease
por: Meoli, Aniello, et al.
Publicado: (2022)